CB(2) cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway

The pharmacological activation of the cannabinoid receptor type 2, CB(2), has been shown to elicit anti-tumoral mechanisms in different cancer types. However, little is known about its endogenous role in tumor pathophysiology, and different studies have attributed pro-tumorigenic properties to this...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Martínez, Esther, Martín-Ruiz, Asunción, Martín, Paloma, Calvo, Virginia, Provencio, Mariano, García, José M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356589/
https://www.ncbi.nlm.nih.gov/pubmed/27634891
http://dx.doi.org/10.18632/oncotarget.11968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356589/
https://www.ncbi.nlm.nih.gov/pubmed/27634891
http://dx.doi.org/10.18632/oncotarget.11968

Ejemplares similares